Theresa Medina, MD, associate professor of medicine-medical oncology at the University of Colorado Cancer Center, Anschutz ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...

Recent studies reveal promising outcomes for discontinuing TKI therapy in select patients with Philadelphia ...

Discover the latest advancements in breast cancer treatment at the 24th Annual International Congress, featuring expert insights and groundbreaking research.

FDA updates CAR T-cell therapy labels for liso-cel and ide-cel, easing monitoring requirements and expanding access for ...

Panelists discuss how to approach a 67-year-old man with advanced polycythemia vera who is resistant to hydroxyurea, ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

A recent trial reveals that nivolumab combined with chemotherapy significantly improves survival rates in older patients with ...

Surbhi Sidana, MD, discusses updates from the CARTITUDE-4 study assessing the CAR T therapy cilta-cel in patients with ...

Despite major advances, real-world data show diminishing survival outcomes and treatment-limiting toxicities in second line ...

Discover how data analytics transforms health care by reducing costs, improving patient outcomes, and enhancing operational ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...